American Association for Cancer Research
Browse
10780432ccr071473-sup-supplementary_data.pdf (710.7 kB)

Supplementary Data from Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma

Download (710.7 kB)
journal contribution
posted on 2023-03-31, 16:05 authored by Hyun Goo Woo, Eun Sung Park, Jae Hee Cheon, Ju Han Kim, Ju-Seog Lee, Bum Joon Park, Won Kim, Su Cheol Park, Young Jin Chung, Byeong Gwan Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Chung Yong Kim, Nam-Joon Yi, Kyung-Suk Suh, Kuhn Uk Lee, In-Sun Chu, Tania Roskams, Snorri S. Thorgeirsson, Yoon Jun Kim
Supplementary Data from Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma

History

ARTICLE ABSTRACT

Purpose: The poor prognosis of hepatocellular carcinoma (HCC) is, in part, due to the high rate of recurrence even after “curative resection” of tumors. Therefore, it is axiomatic that the development of an effective prognostic prediction model for HCC recurrence after surgery would, at minimum, help to identify in advance those who would most benefit from the treatment, and at best, provide new therapeutic strategies for patients with a high risk of early recurrence.Experimental Design: For the prediction of the recurrence time in patients with HCC, gene expression profiles were generated in 65 HCC patients with hepatitis B infections.Result: Recurrence-associated gene expression signatures successfully discriminated between patients at high-risk and low-risk of early recurrence (P = 1.9 × 10−6, log-rank test). To test the consistency and robustness of the recurrence signature, we validated its prognostic power in an independent HCC microarray data set. CD24 was identified as a putative biomarker for the prediction of early recurrence. Genetic network analysis suggested that SP1 and peroxisome proliferator–activated receptor-α might have regulatory roles for the early recurrence of HCC.Conclusion: We have identified a gene expression signature that effectively predicted early recurrence of HCC independent of microarray platforms and cohorts, and provided novel biological insights into the mechanisms of tumor recurrence.

Usage metrics

    Clinical Cancer Research

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC